2025

Hepatitis E virus infections in people with multiple myeloma: an emerging challenge in the era of immunotherapeutic approaches
Al-Bazaz M, Pischke S, Alsdorf W, Sonnemann P, Cichutek S, Wiesch J, Schaefers C, Artzenroth J, Leypoldt L, Kamili A, Bokemeyer C, Weisel K, Kosch R
HAEMATOLOGICA. 2025 [Epub ahead of print].

Activity of CAR-T cells and bispecific antibodies in multiple myeloma with extramedullary involvement
Steinhardt M, Schaefers C, Leypoldt L, Blau I, Harzer M, Zhou X, Riedhammer C, Kamili A, Kosch R, Topp L, Molwitz I, Gross-Fengels N, Melzer Y, Artzenroth J, Al-Bazaz M, Alsdorf W, Topp M, Duell J, Mersi J, Waldschmidt J, Bokemeyer C, Einsele H, Kortüm K, Weisel K, Rasche L
BLOOD CANCER J. 2025;15(1):126.

2023

Combining Poly-(ARD-Ribose) Polymerase and Programmed Cell Death Protein 1 Inhibition in a Patient with Esophagogastric Adenocarcinoma
Artzenroth J, Tintelnot J, Haag G, Gökkurt E, Steffens J, Stein A
ONCOL RES TREAT. 2023;46(7-8):320-325.

Letzte Aktualisierung aus dem FIS: 05.10.2025 - 00:34 Uhr